"Marked slowdown" in French health care spending

29 April 2007

French health care spending slowed markedly in March, after two months in which there was a flu epidemic and a surge in the number of cases of gastro-enteritis. Spending excluding hospital treatment rose 2.2% over March 2006 and contrasted with a 5.6% increase in February this year, according to figures from the health fund organization, the CNAM.

The CNAM has said it remains to be seen whether the slowdown constitutes a trend. Reimbursement rose 4.3% in the first quarter of 2007 over the same year-earlier quarter with a rise of 4.8% registered in general practice medicine. This compares with a target set by the Parliament of 1.1% growth.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight